Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-19 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
24/07/26	NOK 0.2920	-1.68%	439,722
23/07/26	NOK 0.2970	-0.50%	337,042
22/07/26	NOK 0.2985	+4.37%	474,546
21/07/26	NOK 0.2860	-4.67%	584,682
20/07/26	NOK 0.3000	+5.26%	1,094,805

Real-time Oslo Bors

More quotes

Income Statement and Estimates

More financial data

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Real-time Oslo Bors Other stock markets 11:56:04 24/07/2026 BST			5-day change	1st Jan Change
0.2920 ^NOK	-1.68%		+2.46%	-91.04%

07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT

Market Cap	88.54M 9.2M 8.09M 7.52M 6.92M 12.97M 891M 13.2M 89.91M 35.07M 435M 34.55M 33.8M 1.51B	P/E 2026 *	-0.78x	P/E 2027 *	-1.06x
Enterprise Value	125M 12.94M 11.38M 10.58M 9.73M 18.24M 1.25B 18.57M 126M 49.33M 611M 48.59M 47.54M 2.12B	EV / Sales 2026 *	-	EV / Sales 2027 *	25.3x
Free-Float	89.66%	Yield 2026 *	-	Yield 2027 *	-

07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT
06-26	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
06-10	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
05-15	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
05-15	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-15	Lifecare Q1 operating loss NOK 31.5 mln	RE
04-23	Lifecare ASA Approves Board Appointments	CI
03-26	Lifecare ASA Announces Operational Restructuring And Centralization Of Operations	CI
03-26	Lifecare ASA Announces Discontinuation of the Business Operations of Lifecare Germany GmbH	CI
03-26	Lifecare ASA to Close German Operations, Consolidate Activities Under Planned Centralization	MT
03-16	Lifecare Chief Scientific Officer to Step Down	MT
03-13	Andreas Pfützner to Step Down as Chief Scientific Officer of Lifecare ASA	CI

07-02	LIFE: Update on production transfer and longevity programme	AQ
06-26	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU
06-22	LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation	AQ
06-12	Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue	PU
06-10	Lifecare ASA: Mandatory notification of trade	PU

Lifecare ASA Share Price

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news : Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Course Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

1 day	-1.68%
1 week	+2.46%
Current month	+1.04%
1 month	-4.26%
3 months	-25.13%
6 months	-57.06%
Current year	-91.04%

1 week	0.28	0.3
1 month	0.27	0.32
Current year	0.27	2
1 year	0.27	23.5
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	06/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	31/03/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	29/02/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	25/06/2020
Morten Foros Krohnstad CHM	Chairman	-	07/05/2021
Lutz Heinemann BRD	Director/Board Member	-	19/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	-1.68%	+2.46%	-93.32%	-98.82%	9.2M
LONZA GROUP AG	+1.18%	-3.35%	-3.11%	+13.04%	46.35B
REVOLUTION MEDICINES, INC.	+3.13%	+5.34%	+402.93%	+605.08%	40.13B
BEONE MEDICINES AG	+2.14%	+2.95%	+10.83%	+65.45%	36.33B
IQVIA HOLDINGS INC.	+4.43%	-1.51%	+6.73%	-9.17%	34.6B
CELLTRION, INC.	+1.23%	-2.05%	+0.56%	+30.76%	26.77B
ASCENDIS PHARMA A/S	+0.29%	-2.75%	-	-	16.66B
MEDPACE HOLDINGS, INC.	+14.71%	+12.62%	+38.50%	+146.99%	16.91B
EUROFINS SCIENTIFIC SE	+0.70%	-5.26%	+1.03%	+8.79%	13.05B
ICON PUBLIC LIMITED COMPANY	+1.82%	+0.19%	+1.45%	-30.74%	13.05B
Average	+2.67%	+0.47%	+40.62%	+81.26%	24.38B
Weighted average by Cap.	+2.81%	+0.23%	+76.36%	+131.90%

	2026 *	2027 *
Net sales	-	5M 520K 457K 425K 391K 732K 50.33M 745K 5.08M 1.98M 24.55M 1.95M 1.91M 85.16M
Net income	-86M -8.94M -7.86M -7.3M -6.72M -12.6M -866M -12.82M -87.33M -34.06M -422M -33.56M -32.83M -1.46B	-82M -8.52M -7.5M -6.96M -6.4M -12.01M -825M -12.23M -83.27M -32.48M -403M -32M -31.3M -1.4B
Net Debt	36M 3.74M 3.29M 3.06M 2.81M 5.27M 362M 5.37M 36.56M 14.26M 177M 14.05M 13.74M 613M	38M 3.95M 3.47M 3.23M 2.97M 5.57M 382M 5.67M 38.59M 15.05M 187M 14.83M 14.51M 647M